Navigating the New Antipsychotic Quality Measure: Compliance, Coding, and Five-Star Impact
The January 2026 CMS revisions to the Long-Stay Antipsychotic Quality Measure—now incorporating Medicare Fee-for-Service, Medicaid, and Medicare Advantage claims—create a more expansive and sensitive methodology that can trigger the measure even when antipsychotics were not administered during the MDS look-back period. This shift, combined with CMS concerns around underreporting and inaccurate diagnosis coding, places heightened pressure...
Complimentary CE Webinar on Managing Challenges Arising from CMS’s Latest Guidance on Psychotropic Medications and Behavioral Health
Join Pathway Health and Advancing Excellence in Long Term Care Collaborative for the complimentary webinar on July 24, “Managing Challenges Arising from CMS’s Latest Guidance on Psychotropic Medications and Behavioral Health.” Obtain insights on what the latest CMS guidance on psychotropic medications and behavioral health means to patient care and practice management in skilled nursing...